drugset / Trial / NCT06241352

Statin Addition to Chemotherapy for Advanced Pancreatic Cancer

NCT06241352

Phase 2 Completed 42 enrolled Changhai Hospital
NaSingle-groupOpen-labelTreatment

Summary

The results of previous studies conducted by our team have revealed that the use of statins can more effectively hinder the growth of drug-resistant pancreatic cancer cells. The primary objective of this study was to investigate the role of statins in treating pancreatic cancer by assessing the safety and therapeutic impact of combining chemotherapy with statins in patients with advanced pancreatic cancer.

Timeline

Start
2024-03-20
Primary completion
2025-04-30
Completion
2025-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 80 mg